TITLE

Pharma industry warned that huge profits in the face of the recession are no reason for complacency

PUB. DATE
January 2010
SOURCE
CMAJ: Canadian Medical Association Journal;1/12/2010 Supplement, Vol. 182, pE22
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article reports on the growth of the pharmaceutical sector in Canada during the global economic recession. Paul Crotty, General Manager of IMS Health Canada Ltd. says that the Canadian pharmaceutical market has redefined resilience by growing 7 percent during the economic recession. He informed that the patented market in Canada accounts for about 18 billion dollars in sales.
ACCESSION #
51229528

 

Related Articles

  • Drug companies should target drug plans, rather than physicians, consultant says. Silversides, Ann // CMAJ: Canadian Medical Association Journal;1/12/2010 Supplement, Vol. 182, pE21 

    The article presents views of several experts regarding the focus of pharmaceutical companies. Paul Crotty, General Manager of IMS Health Canada Ltd. says that pharmaceutical companies should increase their focus on public and private drug plans rather than physicians. Bob Nakagawa, assistant...

  • European R&D buoyant. Dorey, Emma // Nature Biotechnology;Jan2011, Vol. 29 Issue 1, p10 

    The article reports that the 2008-2009 global economic crises had little effect on biopharmaceutical companies in Europe, according to the 2011 European Union (EU) Industrial R&D Investment Scorecard released by the European Commission.

  • Cómo afecta la coyuntura a la tipología de profesionales reclutados en la industria farmacéutica española? BLANCHIN, GUILLAUME // Capital Humano;Jun2009, Vol. 22 Issue 233, p108 

    The article notes job positions in the Spanish pharmaceutical industry for which candidates continue to be in high demand, despite the global economic slow-down. It explains that pharmaceutical companies are seeking to fill positions related to increasing international market share, including...

  • Pharmaceutical Industry Annual Report of 2009 on Injury Early Warning.  // China Chemical Reporter;2/6/2010, Vol. 21 Issue 3, p13 

    The article features the Industry Injury Early Warning Mechanism for the Pharmaceutical Industry from the Bureau of Industry Injury Investigation and the China Chamber of Commerce for Import & Export of Medicines & Health Products (CCCMHPIE) in China. It found that the sector has maintained...

  • PHARMACEUTICALS' STRONG IMMUNE SYSTEM. Cordle, Ina Paiva // Journal of Commerce (1542-3867);Fall2009 Cool Cargoes, p16 

    This article reports on the pharmaceuticals' strong resistance to global economic crisis. It observes that even with economic recession, consumers have not cut down on their budget for medicines. It even sees an increased demand for pharmaceuticals which is being looked at as an advantage for...

  • High five: Sectoral gains. Ram, R. Sree; Varma, Tanvi // Money Today;5/28/2009, p15 

    The article analyzes the developments among the different sectors of the Bombay Stock Exchange (BSE) Sensex in India. It relates the growth of BSE Sensex with a 6.4 percent gain, the biggest since 2008. It examines how the Indian automobile industry is growing despite being affected by the...

  • Trends Report: Contract Consulting & Pharmaceutical Services. Douglas, Mark; Glass, Geoffrey M.; Gustines, Rob; Kauffman, Jon S.; Lias, Roger; McCarty, John A.; Ultee, Michiel E. // BioPharm International;Sep2009 Directory, p14 

    The article presents questions and answers related to contract consulting and pharmaceutical services including the effects of global recessions on biopharmaceutical companies and whether companies are strategic in their outsourcing approaches or tactically handling a specific tasks, functions,...

  • Vantage Point. Maynor, Jerry // Medical Marketing & Media;Jan2012, Vol. 47 Issue 1, p24 

    The article presents the author's views on the condition of the pharmaceutical industry in relation to the impact of the government's decision on national healthcare and the global financial crisis.

  • Where will the economic crisis leave pharma and biotech? Kermani, Faiz // Pharmaceutical Technology Europe;Sep2009, Vol. 21 Issue 9, p18 

    The article presents the author's perspectives regarding the impact of global economic crisis on the business condition of pharmaceutical and biotechnology industry in Europe. The author asserts that World Bank projects that volatility will decrease the economy by 3% wherein all businesses are...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics